How are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV?

Show simple item record

dc.contributor.author Goga, Ameena Ebrahim
dc.contributor.author Singh, Yagespari
dc.contributor.author Jackson, Debra
dc.contributor.author Mukungunugwa, Solomon
dc.contributor.author Wafula, Rose
dc.contributor.author Eliya, Michael
dc.contributor.author Ng’ambi, Wingston Felix
dc.contributor.author Nabitaka, Linda
dc.contributor.author Chirinda, Witness
dc.contributor.author Bhardwaj, Sanjana
dc.contributor.author Essajee, Shaffiq
dc.contributor.author Hayashi, Chika
dc.contributor.author Pillay, Yogan
dc.date.accessioned 2020-07-16T14:26:50Z
dc.date.available 2020-07-16T14:26:50Z
dc.date.issued 2019
dc.description.abstract Vertical transmission of HIV can occur during pregnancy, delivery, or through breast feeding. The main driver of vertical transmission is a high maternal viral load. Between 2002 and 2016, low and middle income countries (LMICs) in sub-Saharan Africa with high HIV prevalence improved their policies to prevent vertical transmission of HIV. In 2002, national policies recommended single dose nevirapine at the onset of labour, with limited or no breast feeding. By 2016, all Global Plan priority countries in sub-Saharan Africa (where 90% of the world’s HIV positive pregnant women live) had adopted Option B+ with promotion of breast feeding. Option B+ was a dramatic policy change recommending lifelong triple antiretroviral therapy (ART) for all pregnant and lactating women living with HIV. The aim is to protect the child from HIV infection, ensure the mother’s future health, and prevent horizontal transmission of HIV. en_ZA
dc.description.department Paediatrics and Child Health en_ZA
dc.description.librarian am2020 en_ZA
dc.description.sponsorship The South African Medical Research Council (SAMRC) en_ZA
dc.description.uri http://www.bmj.com/thebmj en_ZA
dc.identifier.citation Goga, A., Singh, Y., Jackson, D. et al. How are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV? BMJ 2019;364:l660 http://dx.DOI.org/10.1136/bmj.l660. en_ZA
dc.identifier.issn 0959-8138 (print)
dc.identifier.issn 1756-1833 (online)
dc.identifier.other 10.1136/bmj.l660
dc.identifier.uri http://hdl.handle.net/2263/75325
dc.language.iso en en_ZA
dc.publisher BMJ Publishing Group en_ZA
dc.rights © The Author(s). 2019. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 Internationa License. en_ZA
dc.subject Transmission en_ZA
dc.subject Infection en_ZA
dc.subject Pregnancy en_ZA
dc.subject Human immunodeficiency virus (HIV) en_ZA
dc.subject Vertical transmission en_ZA
dc.subject Low- and middle-income countries (LMICs) en_ZA
dc.subject Sub-Saharan Africa (SSA) en_ZA
dc.subject Antiretroviral therapy (ART) en_ZA
dc.title How are countries in sub-Saharan African monitoring the impact of programmes to prevent vertical transmission of HIV? en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record